Ka lāʻau "Cavintonum forte"

E hoomakaukau ai "Cavinton forte" me kaʻeleu ke keʻena he vinpocetine. Ke medicament mea he nui hou ma ka lolo koko a me ka rheological waiwai (pele) o ke koko.

Kaluakauwa papa "Cavinton" i ke keʻokeʻo (a kokoke keʻokeʻo) waihoʻoluʻu a pau,ʻaʻohe ala. Ma kekahiʻaoʻao ma laila ua kii o «CAVINTON».

Medicine "Cavintonum" (papa): Na Ke Kumu

Ka lapaʻauʻia he cerebroprotective keiki. O ia hoʻi, "Cavintonum forte" mea hiki ke emi i ka hōʻike o cytotoxic reactions hoʻonāukiuki ma ka noho haumāna kahi'amino nāʻakika. Ka lāʻau i ka noho haumāna kahi ia ma cerebral pūnao, iaono? Ienoai digestion a me ka omo o ka monakō koko a me ka oxygen ma ma o ka lolo.

Medicament "Cavintonum forte" maoli he koko selectively. O ia hoʻi, hiki ia oe listen minuke buke hapa iki o ka lolo, emi vascular ia'ku me impacting i kaʻikepili o ka huina koko (cardiac auaiaea, ke koko, naau kōmi).

I ka hoʻohana 'ana i kēia ka lapaʻauʻia o ka hoomahuahua i loko o ke koko na lako i ka iʻa (ischemic) akā, viable wahi me ka haahaa infusion (perfusion).

Ka lāʻau 'ke hoʻoulu i ka cerebral pūnao (pūnao) o ka serotonin a me ka norepinephrine, mai ka antioxidant hopena.

Ka hopena Cavinton hoʻokāʻoi aʻe ana i portability cerebral hypoxic keena. Ka mea, 'aʻole hoʻi i ka aggregation o platelets, iaono? Ienoai ka microcirculation o ka lolo ho'ēmi i kā ka hyperviscosity o pathological ano, maoli ka deformability o erythrocytes, ka paleʻana i ka uptake o adenosine.

I neurology noi 'o ia hoʻi "Cavinton forte" i mea e pono me ka lawa cerebral koko i ka maʻi a me ka huʻi (i holopono nō hahauʻana, transient ischemic Hawaii ma hope o hahauʻana, atherosclerosis, cerebrovascular dementia, hypertensive a me ka lāʻau kū-traumatic encephalopathy , a me na mea e ae). Ka lāʻau 'Ua kekahi hōʻike ma ka neurologic a psychiatric kāna hana me ka cerebrovascular insufficiency (me pōniuniu, iaiyoe kāna hana, apraxia, headache, Hawaii kāna hana).

Ka ophthalmic lāʻau "Cavinton forte" ia vascular pathologies maka (retina a me choroid vasoconstriction, atherosclerosis, haumāna glaucoma, a me na mea e ae).

Ke medicament hoʻohana ma o ka iapaau ana o mauka naehana maʻi (makahiki me ka lohe poho,ʻawahia ole vascular me Kinohi (Kinohi)), Meniere ka maʻi, tinnitus, a me vasovegetative hoikeana o climacteric maʻi pale.

Contraindications i ke kuhikuhi "Cavinton forte" i lactation a me ka hāpai keiki, cardiac ole ma loa 'ano apau loa, e like me hypersensitivity e vinpocetine a kākoʻo eiiiiiaiou.

Ka laʻau heluna a me ka lōʻihi like 'ole o ka pākōlea papa ua hoonohoia ke kauka pākahi. E like me ka rula, ka mea, ke kala, e lawe i ka papaʻekolu manawa i ka lā. Inu ka lapaʻauʻia paipaiʻia ma hope o kaʻai. Ka pākōlea holo ana i hope mai kekahi i ka ewalu mahina, e like me ka rula, he awelika o ka ekolu i eha mahina. Inā e ana i ka lāʻau laʻau heluna ua hoemi ke kiʻekiʻe ma luna o elua a ekolu lā.

E ho ohana ana i ka lāʻau 'hiki i exacerbations o na arrhythmias. I kekahi manawa, ua maloo waha, nawaliwali, heartburn, Kanikani'āʻula, ili poʻe noʻonoʻoʻole, nausea, headache, hives, flushing o ka ili.

Cavintonum aohe hepatotoxicity a me ka nephrotoxicity i loko o kēia e pili ana i ka wa a lawelawe i nā mea maʻi me ka akepaʻa a me nā konāhua mai, ka laʻau heluna regimen ua i koi 'ia e hooponopono.

Ke k ua i paipai no ka hoʻohana i ka poʻe mamo makahiki emi ma mua o 18 ma muli o ke lawa study o ka aoao o kona eiiiiiaiou ma luna o ke kino o ke keiki ka.